What are the causes of protein-losing enteropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Protein-Losing Enteropathy

Protein-losing enteropathy results from three primary mechanisms: erosive gastrointestinal disorders causing mucosal damage, non-erosive gastrointestinal disorders with increased mucosal permeability, and conditions causing elevated central venous pressure or lymphatic obstruction. 1, 2

Primary Etiologic Categories

Erosive Gastrointestinal Disorders

These conditions cause direct mucosal damage leading to protein leakage:

  • Inflammatory bowel disease (Crohn's disease) presents with bloody diarrhea, fever, weight loss, and shows aphthous ulceration, skip lesions, and granulomas on biopsy 3
  • Infectious enteritis including tuberculosis (with granulomatous disease, cough, ascites, night sweats), Mycobacterium avium complex, giardiasis, and Whipple's disease (with PAS-positive macrophagic infiltration) 3
  • Eosinophilic gastroenteritis characterized by multiple allergies, atopy, and massive eosinophilic infiltration on biopsy 3

Non-Erosive Gastrointestinal Disorders

These cause protein loss through increased mucosal permeability without erosions:

  • Primary intestinal lymphangiectasia (Waldmann's disease) represents lymphatic leakage due to increased interstitial pressure 4, 5
  • Celiac disease and seronegative enteropathy with villous atrophy—both autoimmune enteropathy (with anti-enterocyte/anti-goblet cell antibodies, absence of Paneth or goblet cells) and tropical sprue (requiring travel to tropical countries, with folate/B12 deficiency) 3, 6
  • Common variable immunodeficiency disease presenting with low total IgG, IgA, and IgM levels 3
  • Medication-induced enteropathy from olmesartan (causing severe illness that responds rapidly to cessation), other angiotensin receptor blockers, mycophenolate mofetil, methotrexate, and azathioprine 3, 1
  • Microscopic colitis as part of the differential for persistent diarrhea 3

Cardiac and Lymphatic Obstruction Disorders

Elevated central venous pressure or lymphatic obstruction causes protein loss:

  • Fontan circulation in congenital heart disease—protein-losing enteropathy occurs in patients with elevated Fontan pressures and correlates with poor outcomes 3, 1
  • Constrictive pericarditis causing elevated venous pressure requiring surgical pericardiectomy for definitive treatment 1, 7
  • Restrictive cardiomyopathy and tricuspid valve disease (stenosis or insufficiency) 7
  • Superior or inferior caval venous obstruction—restoration of unobstructed caval flow may be curative 7

Additional Causes

  • Radiation enteropathy following pelvic irradiation (>45 Gy), particularly affecting sigmoid and terminal ileum, causing malabsorption, protein loss, diarrhea, and obstruction months to years after treatment 3
  • Systemic sclerosis and connective tissue disorders with smooth muscle atrophy and gut wall fibrosis 3
  • Amyloidosis (primary type, often with myeloma producing lambda chains) causing both myopathy and neuropathy 3
  • HIV enteropathy with decreased CD4+ T lymphocytes 3
  • Graft-versus-host disease following bone marrow transplantation, showing crypt cell necrosis and epithelial loss 3
  • Small intestinal bacterial overgrowth in patients with anatomical abnormalities or poor motility 3

Critical Diagnostic Pitfall

A common error is diagnosing celiac disease based solely on villous atrophy without performing serologic testing first. 3 Patients with villous atrophy from other causes will not respond to a gluten-free diet. If celiac serology is negative and villous atrophy persists despite gluten-free diet, systematically evaluate for the alternative causes listed above, particularly medication-induced enteropathy, common variable immunodeficiency, autoimmune enteropathy, tropical sprue, infections, and lymphoproliferative disorders 3

References

Guideline

Protein-Losing Enteropathy Treatment Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Protein-losing enteropathy: case illustrations and clinical review.

The American journal of gastroenterology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical practice. Protein-losing enteropathy in children.

European journal of pediatrics, 2010

Research

[Protein-losing enteropathy].

La Revue de medecine interne, 2015

Research

[A case of protein-losing enteropathy associated with small bowel villous atrophy].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.